Facilitated a successful preferential issue for Sanjivani Paranteral, enhancing capital structure

Sanjivani Parenteral Limited is an Indian pharmaceutical company which specializes in the production and marketing of pharmaceutical products, focusing on the development of parenteral drugs, which are administered directly into the body. Sanjivani's expertise spans across manufacturing sterile products and leveraging advanced technologies to ensure high-quality standards in its offerings. Ashika Capital managed and guided Sanjivani Paranteral through the preferential issue process.